|Bid||36.61 x 2000|
|Ask||36.64 x 7400|
|Day's Range||36.55 - 36.80|
|52 Week Range||23.62 - 38.21|
|PE Ratio (TTM)||18.43|
|Dividend & Yield||0.86 (2.35%)|
|1y Target Est||N/A|
Dutch healthcare company Philips (PHG.AS) has agreed to buy U.S.-based Spectranetics Corp (SPNC.O), a maker of devices to treat heart disease, for 1.9 billion euros ($2.16 billion) including debt, as it expands its image-guided therapy business. Spectranetics uses techniques including lasers and tiny drug-covered balloons to clean the insides of veins and arteries that have become clogged due to heart disease. Philips will pay Spectranetics shareholders $38.50 per share, a 27 percent premium to their closing price on June 27.
Royal Philips said Wednesday that it will buy medical devices maker Spectranetics Corporation in a deal that carries an enterprise value of around €1.9 billion.
THE HAGUE, Netherlands (AP) — Dutch electronics and health care technology company Philips says it has an agreement to buy The Spectranetics Corporation in a deal worth 1.9 billion euros ($2.2 billion).